Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes

被引:131
作者
Campo, Giuseppe M. [1 ]
Avenoso, Angela [1 ]
Campo, Salvatore [1 ]
D'Ascola, Angela [1 ]
Nastasi, Giancarlo [1 ]
Calatroni, Alberto [1 ]
机构
[1] Univ Messina, Policlin Univ, Sch Med, Dept Biochem Physiol & Nutr Sci, I-98125 Messina, Italy
关键词
Hyaluronan; Lipopolysaccharides; Cytokines; Chondrocytes; NF-kB factor; EXTRACELLULAR-MATRIX; DENDRITIC CELLS; DANGER SIGNAL; FRAGMENTS; INJURY; TLR4; IMMUNITY; REPAIR; OLIGOSACCHARIDES; OSTEOARTHRITIS;
D O I
10.1016/j.biochi.2009.10.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyaluronan (HA) action depends upon its molecular size. Low molecular weight HA elicits pro-inflammatory responses by modulating the toll-like receptor-4 (TLR-4) or by activating the nuclear factor kappa B (NF-kB). In contrast, high molecular weight HA manifests an anti-inflammatory effect via CD receptors and by inhibiting NF-kB activation. Lipopolysaccharide (LPS) -mediated activation of TLR-4 complex induces the myeloid differentiation primary-response protein (MyD88) and the tumor necrosis factor receptor-associated factor-6 (TRAF-6), and ends with the liberation of NF-kB/Rel family members. The aim of this study was to investigate the influence of HA at different MWs (low, medium, high) on TLR-4 modulation in LPS-induced inflammatory response in mouse chondrocyte cultures. Messenger RNA and related protein levels were measured for TLR-4, MyD88, and TRAF-6 in both untreated and LPS-treated chondrocytes, with and without the addition of HA (two doses for each MW). NF-kB activation, TNF-alpha and IL-1 beta levels, matrix metalloprotease-13 (MMP-13), and inducible nitric oxide synthase (iNOS) gene expression were also evaluated. LPS increased all the parameters studied as well as NF-kB activation. Low MW HA upregulated TLR-4 expression, increased MyD88 and TRAF-6 and the inflammation mediators in untreated chondrocytes. and it enhanced the LPS effect in LPS-treated cells. Medium and high MW HA exerted no activity in untreated cells and only the latter reduced the LPS effects. Specific TLR-4 blocking antibody was utilised to confirm TLR-4 as the target of HA action. These findings suggest that the regulatory effect exerted by HA (at any MW) on NF-kB activation may depend upon the interaction between HA and TLR-4 and HA may thereby modulate pro-inflammatory activity via its different state of aggregation. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 43 条
  • [1] Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis
    Abdollahi-Roodsaz, Shahla
    Joosten, Leo A. B.
    Roelofs, Mieke F.
    Radstake, Timothy R. D. J.
    Matera, Giovanni
    Popa, Calin
    van der Meer, Jos W. A.
    Netea, Mihai G.
    van den Berg, Wim B.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (09): : 2957 - 2967
  • [2] Fragments of extracellular matrix as mediators of inflammation
    Adair-Kirk, Tracy L.
    Senior, Robert M.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7) : 1101 - 1110
  • [3] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [4] Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large
    Beutler, Bruce
    Jiang, Zhengfan
    Georgel, Philippe
    Crozat, Karine
    Croker, Ben
    Rutschmann, Sophie
    Du, Xin
    Hoebe, Kasper
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 353 - 389
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Cantor Jerome O., 2006, Inflammation & Allergy Drug Targets, V5, P257, DOI 10.2174/187152806779010936
  • [7] Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway
    Chen, Taoyong
    Guo, Jun
    Han, Chaofeng
    Yang, Mingjin
    Cao, Xuetao
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (03) : 1449 - 1459
  • [8] EBERLEIN M, 2008, J INFLAMM, V5, P5
  • [9] Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy
    Farkkila, Martti
    Rautiainen, Henna
    Karkkainen, Paivi
    Karvonen, Anna-L.
    Nurmi, Heimo
    Niemela, Onni
    [J]. LIVER INTERNATIONAL, 2008, 28 (06) : 787 - 797
  • [10] At the horizon of innovative therapy in rheumatology: new biologic agents
    Finckh, Axel
    Gabay, Cem
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 269 - 275